AzTrials
AzTrials

Physical Conditioning, HumanNCT02075944

Effects of Aerobic Exercise on Cognitive Function and Brain-derived Neurotrophic Factor in Young Adults

A study testing High intensity aerobic exercise and Low intensity aerobic exercise in people with Physical Conditioning, Human and Cognition, run by University of Southern Denmark at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study will investigate the effects of aerobic exercise on cognition and growth factors including brain-derived neurotrophic factor (BDNF) in young adults aged 15-21 years. The included subjects will be randomized to three different groups including one control group and two exercise groups. Read more about this study

Who is it for?
Ages 15 to 21 yearsHealthy volunteers can take part
Conditions the study is for
Physical Conditioning, Human, Cognition
What is being tested?
High intensity aerobic exercise and Low intensity aerobic exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteDenmark
Study dates
Feb 2014to Jun 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 21 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • age 15-21

Who cannot join

  • injury preventing one from being physically active

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • University of Southern Denmark

    Odense, 5000

Other trials in Denmark

About this study

Official title: Effects of Aerobic Exercise on Cognitive Function and Brain-derived Neurotrophic Factor in Young Adults Aged 15-21 Years

The present study will investigate the effects of aerobic exercise on cognition and growth factors including brain-derived neurotrophic factor (BDNF) in young adults aged 15-21 years. The included subjects will be randomized to three different groups including one control group and two exercise groups. Subjects randomized to the exercise groups will complete 30 minutes of aerobic exercise 3 times a week for 9 weeks incorporating low (group I) or high (group II) intensity aerobic exercise. The exercise will be conducted as running or indoor cycling (supervised). At baseline and 9-weeks follow-up all subjects will complete two cognitive tests (measures of concentration and sustained attention), a maximal cycling test (direct measures of VO2max), an intelligence quotient test, anthropometric measures, fasting blood samples and blood samples immediately following the cycling test. The blood samples will be analyzed for growth factors including BDNF and metabolic factors.

Being tested
High intensity aerobic exercise, Low intensity aerobic exercise
Keywords
Aerobic exercise, Cognitive function, Executive function, Brain-derived neurotrophic factor
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High intensity aerobic exerciseBehavioural

  • Low intensity aerobic exerciseBehavioural

Study groups in NCT02075944
Study groupRoleWhat they receive
High intensity aerobic exerciseExperimental30 minutes of high intensity aerobic exercise 3 times a weeks for 9 weeks - incorporation interval training
Receives: Behavioral: High intensity aerobic exercise
Low intensity aerobic exerciseExperimental30 minutes of low intensity aerobic exercise 3 times a weeks for 9 weeks
Receives: Behavioral: Low intensity aerobic exercise
ControlNo interventionNo intervention. Participants are told not to make any changes in their everyday life

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Flanker Task

    Measured: 9 weeks

  2. The AX-Continuous Performance test

    Measured: 9 weeks

  3. Brain-derived neurotrophic factor

    Measured: 9 weeks

Secondary outcomes (1)
  1. Intelligence quotient

    Measured: 9 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2014 (estimated)
  2. Study startFeb 2014
  3. Primary completionJun 2014
  4. Study completionJun 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Investigator
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02075944
Sponsor's protocol ID
S-20130171
Status last verified
Jun 2014
First submitted
27 Feb 2014
Last updated
26 Jun 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Gejl AK, Bugge A, Ernst MT, Mortensen EL, Gejl KD, Andersen LB. Effects of 9 Weeks of High- or Moderate-Intensity Training on Cardiorespiratory Fitness, Inhibitory Control, and Plasma Brain-Derived Neurotrophic Factor in Danish Adolescents-A Randomized Controlled Trial. Scand J Med Sci Sports. 2024 Aug;34(8):e14703. doi: 10.1111/sms.14703.

    PubMed 39054765

Questions about this trial

What is this clinical trial studying?

A study testing High intensity aerobic exercise and Low intensity aerobic exercise in people with Physical Conditioning, Human and Cognition, run by University of Southern Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Flanker Task (time frame: 9 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02075944, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in